Close Menu
    Saudi ScribeSaudi Scribe
    • Automotive

      Jaguar Type 01 electric GT debuts with 1,030 PS

      October 7, 2026

      Porsche to cut 5000 more jobs under restructuring plan

      July 28, 2026

      Japan new car sales rise 1.8% in first half of 2026

      July 2, 2026

      Porsche reveals bespoke 911 GT3 RS in Macadamiametallic

      May 18, 2026

      Mercedes-Benz unveils electric C-Class in Seoul

      April 21, 2026
    • Business

      Morocco secures €434.4 million AfDB loan for reforms

      November 14, 2026

      ATI secures Manila South Harbour concession to 2063

      November 13, 2026

      Southeast Asia needs $7.1 trillion for infrastructure by 2040

      November 12, 2026

      Ghana Minority demands funding plan for $10bn New Economy

      November 11, 2026

      Samsung cash pile tops 200 trillion won, a first in Korea

      November 9, 2026
    • Entertainment

      Sony confirms God of War trilogy remake and PS5 prequel

      February 13, 2026

      Apple Arcade adds Jeopardy and NFL games in September update

      August 19, 2025

      Moscow hosts historic 47th international festival

      April 19, 2025

      Legal action against ‘Ketamine Queen,’ doctors in Perry overdose

      August 17, 2024

      Web3 leader Immutable rolls out $50M gaming rewards initiative

      April 27, 2024
    • Health

      Africa CDC says Congo Ebola outbreak still not under control

      November 16, 2026

      WHO reports 67 yellow fever cases in nine African countries

      November 7, 2026

      Bangladesh dengue deaths reach 418 after deadliest month of 2026

      November 2, 2026

      DR Congo Ebola death toll climbs to 5,340 as cases reach 10,351

      November 2, 2026

      DR Congo Ebola cases top 10,000 in fastest-growing outbreak

      October 28, 2026
    • Lifestyle

      JP Morgan funds Fresha with $31 million for AI and robotics growth

      August 23, 2024

      Adidas, Highsnobiety debut limited-edition sneakers

      January 6, 2024

      Unraveling Starbucks’ phenomenon as a worldwide coffee powerhouse

      September 1, 2023

      How Nike’s Kobe 8 Protro Halo Marks an Emotional Milestone

      August 29, 2023

      From labels to legacy – understanding fashion’s hierarchy

      August 21, 2023
    • Luxury

      Global luxury market contracts for first time since Great Recession

      November 18, 2024

      Uncover the allure of Rolex Deepsea – luxury awaits.

      April 10, 2024

      Beyond timekeeping to the prestige of the Rolex Day-Date

      March 2, 2024

      Rare uncut emerald dazzles at Sharjah show

      February 1, 2024

      Porsche and Frauscher launch the electric 850 Fantom Air

      October 17, 2023
    • News

      UAE and Timor-Leste presidents discuss stronger bilateral ties

      November 16, 2026

      UAE President, Arab League chief discuss regional security

      November 14, 2026

      China, Türkiye and Ethiopia launch carbon credit initiative

      November 13, 2026

      EU and Nigeria sign agreement to speed up migrant returns

      November 12, 2026

      Modi tells Zelenskyy India ready to help end Ukraine conflict

      November 11, 2026
    • Sports

      Dakar 2026 Youth Olympic Games open Saturday in Senegal

      October 30, 2026

      Ballon d’Or 2026 nominees confirmed for London ceremony

      September 9, 2026

      Lionel Messi retires from Argentina after 21-year record run

      September 1, 2026

      Portugal fall to Spain as Ronaldo legacy closes

      July 7, 2026

      Brazil exits World Cup after Norway Round of 16 victory

      July 6, 2026
    • Technology

      MEAPMP Launches: Revamped Independent Ad-Tech & Premium Media Buying Across MEA

      November 3, 2026

      Apple iPhone Duo review: an engineering triumph for foldables

      November 2, 2026

      Apple unveils MacBook Pro with OLED display and touchscreen

      October 29, 2026

      Integrated Identity Ranks in Top 0.1% with Flawless 100/100 Google PageSpeed

      October 29, 2026

      Russian, Chinese scientists develop ultrasonic welding method

      October 21, 2026
    • Travel

      Türkiye targets $70 billion in tourism revenue in 2027

      October 21, 2026

      Air Arabia adds new Sharjah to Amman City Airport route

      October 9, 2026

      Air Arabia restores daily Ras Al Khaimah Kozhikode flights

      October 7, 2026

      flydubai showcases growing Syria network at Damascus show

      September 29, 2026

      Fleet expands as Emirates enters winter season with strong bookings

      September 15, 2026
    Saudi ScribeSaudi Scribe
    Home » Innovative Immunology Biotech Windward Bio Lists on Nasdaq
    PR Newswire

    Innovative Immunology Biotech Windward Bio Lists on Nasdaq

    November 14, 2026
    Facebook WhatsApp Twitter Pinterest LinkedIn Telegram Tumblr Email Reddit VKontakte

    SHANGHAI, Nov. 14, 2026 /PRNewswire/ — Windward Bio, a portfolio company of Qiming Venture Partners and a clinical-stage biotechnology company, successfully listed on Nasdaq on November 13, 2026. Windward Bio (Nasdaq: WWB) priced its IPO at $17.00 per share. Its shares closed at $28.50 on the first trading day, up 68% from the IPO price, giving the company a market capitalization of approximately $1.69 billion. This is Qiming Venture Partners’ 11th IPO in 2026.

    Qiming Venture Partners invested in Windward Bio’s inaugural Series A financing in 2025 and continued to support the company in its Series B financing in 2026. Qiming also participated in this IPO financing round.

    Windward Bio was founded in 2024 with a mission to transform the treatment paradigm for patients living with chronic inflammatory diseases through the development of differentiated biologic therapies targeting clinically validated disease pathways. Led by a team with extensive expertise across discovery, development, and commercialization, Windward Bio is advancing a pipeline of ultra-long-acting antibody medicines to improve clinical outcomes, reduce treatment burden and expand treatment options for patients with serious respiratory and dermatologic diseases, including asthma, chronic obstructive pulmonary disease (COPD) and atopic dermatitis.

    Windward Bio’s lead program, WIN378, is a potentially novel anti-TSLP monoclonal antibody engineered for improved potency and extended half-life. WIN378 is currently being evaluated in POLARIS-1, a Phase 2/3 study in severe uncontrolled asthma, and SIRIUS, a Phase 2 study in COPD. The company’s pipeline also includes WIN027, a clinical-stage, long-acting bispecific antibody targeting TSLP and IL-13 with potential applications across multiple inflammatory and immunological diseases. Windward Bio holds exclusive global rights (excluding Greater China and certain Asian countries) to WIN378 through a licensing agreement with Kelun-Biotech and Harbour BioMed, and has separately licensed WIN027 from Qyuns Therapeutics.

    “Qiming Venture Partners invests in differentiated, globally competitive biotech innovation designed to address significant unmet needs for patients, and Windward Bio exemplifies this approach. We believe novel, long-acting biologics will reshape the treatment of severe chronic respiratory and skin diseases, and that WIN378 and WIN027 have the potential to expand and meaningfully improve the treatment options available to patients. In the hands of Luca and his team, with their expertise and proven track record, Windward is well-positioned to deliver on this potential, and we look forward to supporting the company through its next phase of growth,” said Alexander Sinclair Wilson, Principal at Qiming Venture Partners.

    About Qiming Venture Partners

    Qiming Venture Partners was founded in 2006. Currently, Qiming Venture Partners manages eleven US Dollar funds and seven RMB funds with $9.5 billion in capital raised. Since our establishment, we have invested in outstanding companies in the Technology and Healthcare industries at the early and growth stages.

    Since our debut, we have backed over 630 fast-growing and innovative companies. Over 290 of our portfolio companies have achieved exits through IPOs at the NYSE, NASDAQ, HKEX, Shanghai Stock Exchange, or Shenzhen Stock Exchange, or through M&A or other means. There are also over 110 portfolio companies that have achieved unicorn or super unicorn status.

    Many of our portfolio companies are today’s most influential firms in their respective sectors, including Xiaomi, Meituan, Bilibili, Zhihu, Roborock, Hesai Technology, UBTech, WeRide, HyperStrong, Insta360, Unisound, Biren Technology, Z.AI, Gan & Lee Pharmaceuticals, Tigermed, Zai Lab, CanSino Biologics, Schrödinger, APT Medical, Sanyou Medical, AmoyDx, SinocellTech, Insilico Medicine, AusperBio, Yuanxin Technology, Medilink Therapeutics, LaNova Medicines, StepFun, among many others.

    Cision View original content:https://www.prnewswire.co.uk/news-releases/innovative-immunology-biotech-windward-bio-lists-on-nasdaq-302939554.html

    Related Posts

    DAR GLOBAL EXPANDS SAUDI ARABIA PORTFOLIO WITH NEW JEDDAH DEVELOPMENT VALUED AT SAR 1 BILLION

    November 16, 2026

    ZTE Powers High Efficiency AIDC with Robust Energy Infrastructure

    November 16, 2026

    HONOR RANKS NO. 1 AMONG ANDROID SMARTPHONE BRANDS IN CHINA AS MAGIC9 SERIES SALES SURPASS 500,000 UNITS

    November 16, 2026

    Phoenix Contact Training Team Sets New Guinness World Record in Wiring

    November 16, 2026

    Thunes Expands Real-Time Payouts to Bhutan, Unlocking the Nation’s Remittance Market

    November 16, 2026

    WHO Bahrain and RCSI Medical University of Bahrain sign agreement to strengthen health workforce education, research and community engagement

    November 15, 2026
    Latest News

    Africa CDC says Congo Ebola outbreak still not under control

    November 16, 2026

    UAE and Timor-Leste presidents discuss stronger bilateral ties

    November 16, 2026

    UAE President, Arab League chief discuss regional security

    November 14, 2026

    Morocco secures €434.4 million AfDB loan for reforms

    November 14, 2026
    © 2026 Saudi Scribe | All Rights Reserved
    • Home
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.